The increase of PROX1-AS1 expression in RCC-derived cells (796-P and A498) after the same treatment could indicate that this effect was due to other phenomena (i.e., transcription factors, other non-coding RNA, etc.). This evidence concerns the gene PROX1 and renal cell carcinoma.